Allarity Therapeutics, Inc.

Allarity Therapeutics, Inc.

Biotechnology • Healthcare • Boston, MA, United States • ALLR (NCM)

Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing novel anti-cancer therapeutics for patients with unmet medical needs. The company develops drugs for the personalized treatment of cancer using drug specific companion diagnostics generated by its proprietary drug response predictor technology. Its lead drug candidate includes Stenoparib, a novel dual inhibitor of poly-ADP-ribose polymerase (PARP1/2) that is being evaluated in a phase 2 clinical trial in patients with advanced and recurrent ovarian cancer. The company also develops stenoparib- DRP, a companion diagnostic product used in select patients for stenoparib treatment. Allarity Therapeutics, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

401 426 4664 24 School Street, Boston, MA 02108, United States

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Cancer drug progress, cash runway updates in Allarity's year-end CEO letter - Stock Titan
Stock Titan • Dec 31
Allarity Therapeutics Issues 2025 End of Year CEO Letter to Shareholders - Sahm
Sahm • Dec 31
Ascendiant Capital Maintains Allarity Therapeutics (ALLR) Buy Recommendation - Nasdaq
Nasdaq • Dec 9
Allarity Therapeutics stock soars after FDA Fast Track designation - Investing.com
Investing.com • Aug 26
Allarity Therapeutics Raises Amidst Promising Developments - StocksToTrade
StocksToTrade • Aug 26

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has Allarity Therapeutics, Inc. had layoffs?
No layoff events have been recorded for Allarity Therapeutics, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does Allarity Therapeutics, Inc. have?
Allarity Therapeutics, Inc. has approximately 6 employees.
What industry is Allarity Therapeutics, Inc. in?
Allarity Therapeutics, Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is Allarity Therapeutics, Inc. a publicly traded company?
Yes, Allarity Therapeutics, Inc. is publicly traded under the ticker symbol ALLR on the NCM. The company has a market capitalization of approximately $0.02 billion.
Where is Allarity Therapeutics, Inc. headquartered?
Allarity Therapeutics, Inc. is headquartered in Boston, MA, United States at 24 School Street, Boston, MA 02108, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.